These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10974501)

  • 41. Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson's disease.
    Zhou B; Yuan F; He Z; Tan C
    Brain Imaging Behav; 2014 Mar; 8(1):97-101. PubMed ID: 23955491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonmotor Features in Atypical Parkinsonism.
    Bhatia KP; Stamelou M
    Int Rev Neurobiol; 2017; 134():1285-1301. PubMed ID: 28805573
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.
    Bertolino A; Nawroz S; Mattay VS; Barnett AS; Duyn JH; Moonen CT; Frank JA; Tedeschi G; Weinberger DR
    Am J Psychiatry; 1996 Dec; 153(12):1554-63. PubMed ID: 8942451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The clinical spectrum of freezing of gait in atypical parkinsonism.
    Factor SA
    Mov Disord; 2008; 23 Suppl 2():S431-8. PubMed ID: 18668624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MR findings in the substantia nigra on phase difference enhanced imaging in neurodegenerative parkinsonism.
    Sugiyama A; Sato N; Kimura Y; Ota M; Maekawa T; Sone D; Enokizono M; Murata M; Matsuda H; Kuwabara S
    Parkinsonism Relat Disord; 2018 Mar; 48():10-16. PubMed ID: 29279191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
    Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y
    Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Proton magnetic resonance spectroscopy and single photon emission CT in patients with olivopontocerebellar atrophy].
    Ikuta N
    Rinsho Shinkeigaku; 1998 Apr; 38(4):289-94. PubMed ID: 9742873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.
    Ko JH; Lee CS; Eidelberg D
    J Cereb Blood Flow Metab; 2017 Feb; 37(2):683-693. PubMed ID: 26980757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.
    Bertolino A; Kumra S; Callicott JH; Mattay VS; Lestz RM; Jacobsen L; Barnett IS; Duyn JH; Frank JA; Rapoport JL; Weinberger DR
    Am J Psychiatry; 1998 Oct; 155(10):1376-83. PubMed ID: 9766769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of Extrastriatal
    Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J
    J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628
    [No Abstract]   [Full Text] [Related]  

  • 52. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.
    Leiguarda RC; Pramstaller PP; Merello M; Starkstein S; Lees AJ; Marsden CD
    Brain; 1997 Jan; 120 ( Pt 1)():75-90. PubMed ID: 9055799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease?
    Feng JY; Huang B; Yang WQ; Zhang YH; Wang LM; Wang LJ; Zhong XL
    Acta Radiol; 2015 Mar; 56(3):322-8. PubMed ID: 24619850
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
    Yamasue H; Fukui T; Fukuda R; Kasai K; Iwanami A; Kato N; Kato T
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):353-60. PubMed ID: 14604450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study.
    Block W; Bayer TA; Tepest R; Träber F; Rietschel M; Müller DJ; Schulze TG; Honer WG; Maier W; Schild HH; Falkai P
    Neurosci Lett; 2000 Aug; 289(2):147-51. PubMed ID: 10904141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dopamine transporter genotype influences N-acetyl-aspartate in the left putamen.
    Scherk H; Backens M; Schneider-Axmann T; Kraft S; Kemmer C; Usher J; Reith W; Falkai P; Meyer J; Gruber O
    World J Biol Psychiatry; 2009; 10(4 Pt 2):524-30. PubMed ID: 17965994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
    Vintonyak O; Gorges M; Müller HP; Pinkhardt EH; Ludolph AC; Huppertz HJ; Kassubek J
    Neurodegener Dis; 2017; 17(4-5):117-126. PubMed ID: 28268209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
    Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences in Striatal Metabolism in [
    Seiffert AP; Gómez-Grande A; Alonso-Gómez L; Méndez-Guerrero A; Villarejo-Galende A; Gómez EJ; Sánchez-González P
    Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.